InPharm Merck to Develop Biosimilar with peninsula Chemical Manufacturer Pharmaceutical application Magazine Merck & Co. and the biobusiness of Hanwha Chemical, a peninsula chemical manufacturer, have settled an exclusive global statement to develop and type A commercialize a biosimilar of Enbrel (etanercept), a drug to treat moderate to severe plaque psoriasis , ... Merck Collaborates with Hanwha Zacks.com Merck & Co inks Enbrel biosimilar pact with Korea's Hanwha Pharma Times Merck Moves Again On Biosimilars natural science & Engineering News each 8 news articles » Link To Article
No comments:
Post a Comment